The BioValley France competitiveness cluster brings together and supports startups, SMEs, large groups, healthcare, and research and training organizations in the French Grand Est area around the health domain.
BioValley France, in partnership with Nathalie Picollet-D’hahan from CEA and Stéphanie Descroix from Institut Curie and Institut Pierre-Gilles de Gennes, produced the first organ-on-chip directory now available in a 100% digital format. In total, 57 dedicated pages bring together researchers from large companies, biotechs & startups, research institutes, hospitals and universities throughout the country. A big step towards promoting the development of personalized medicine!
Structuring the 1st organ-on-chip sector in France
BioValley France began to take an interest in the theme of organs on a chip (OOC) in the spring of 2018. Its first objective, with principals such as large groups, pharmaceutical or dermo-cosmetic, was to identify and define a common need currently little or not offered by the biotechs and more generally by actors in health domain (universities, research institutes, etc.). The objective is to bring about a structuring project that will meet this expressed need.
An initiative driven by both academics and companies
After a first meeting with several large French groups, a significant number of biotechs joined the think tank. It was then completed by numerous public research teams.
Following the various meetings and discussions that have taken place since the first meeting in September 2018, a second objective shared by everyone quickly emerged: “to structure the OoC sector in France”. A dedicated directory, symbolizing the 1st stage of this structuring, was thus created.
Discover the directory right here:
EUROoCS was initiated by the ORCHID (Organ-on-Chip in Development) European consortium of seven academic partners. The ORCHID project has now been finalized and the final report is now available here. The final report describing the achievements of ORCHID and refers to the relevant documents that have been delivered during the 2-year ORCHID project.
The annual Sartorius and Science Prize for Regenerative Medicine and Cell Therapy is geared towards researchers focused on basic or translational research that advances regenerative medicine and cell therapy. The initiators are looking forward to receiving your application before 1 October 2019.
Eligible fields: Entries accepted from the fields of regenerative medicine, cell therapy, gene therapy, immunotherapy, and materials and tissue engineering.
Eligibility: Individual scientists who received their PhD or MD within the past 10 years may apply.
Required documents: Please submit a 1,000-word essay describing your research and its implications for your field, plus supporting documents.
What is there to win?
• US$ 25,000 and a publication of your essay in Science
• Publication in print of the Grand Prize essay and those of up to three runners-up on Science Online
• 5-year AAAS membership and online subscription to Science
• Other perks and benefits from the sponsoring company, Sartorius
On Tuesday 19 March 2019 a one-day Organ-on-Chip symposium was organized by dr. Ben Maoz and dr. Gad Vatine at the Tel Aviv University (TAU) in Israel. It was a lively meeting divided in four parts: Cancer/Metabolism, Vasculature, Technologies and Lab on Chip.
Some 150 attendants watched new work presented in oral presentations and posters, illustrating a very active Israelian Organ on Chip community, with strong presence from a.o. Technion and Tau. External speakers were Joshua Owen (Leeds) and Albert van den Berg (UTwente), while also some startup companies participated (Tissue Dynamics).
Worth mentioning are dr. Maria Khoury (Technion) working on Pulmonary Capillary Networks, dr. Ben Maoz (Tau) with BBB-chip work, dr. Ariel Sklanny (Technion) with advanced vessel sprouting and dr. Gilad Yossifon (Technion) with original sperm sorting work as well as advanced Janus particle research. All in all it demonstrated high-level research being performed in the Israelian Organ-on-Chip network.
The first edition of the two-day conference ‘Life-on-Chip – The Road from Idea to Reality’ in the Provincial House in Leuven was attended by more than 140 international participants, speakers and exhibitors. The participants were all players from the Health/Life Sciences and micro- and nanotechnology sectors.
During the conference Janny van den Eijnden – van Raaij, managing director of hDMT, was invited to present the Dutch hDMT approach to unite the Organ-on-Chip research & development and collaborate to bring this field forward.
Pioneers work on our health of tomorrow: new and better medicines, prostheses, techniques, treatments tailored to the individual patient. To achieve breakthroughs, there must be more cross-fertilization. Not only between the various disciplines within the major field of Health/Life Sciences, but also between Health/Life Sciences and micro- and nanotechnology.
With the ‘Life-on-Chip’ conference, Smart Hub Vlaams-Brabant encouraged these pioneers to cooperate more via networking, a symposium with more than twenty speakers and matchmaking (E.E.N./B2Match).
Because of the great success of this first edition and in order to continue to stimulate cross-fertilization, Smart Hub Flemish Brabant will organize (in collaboration with its partners) more of these conferences in the coming years.
News on Smart Hub Vlaams-Brabant (in Dutch)
The photos of the conference can be found through this link.
You can watch the Life-on-Chip report on Kanaal Z here.
The Life-on-Chip conference is part of a Flemish-wide ERDF project of which the province is the driving force. Partners are flanders.bio, DSP Valley and Leuven MindGate and it is supported by the RegMed community and Flanders Investment & Trade.